Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Hyundai Bioscience Develops Injection Drug for Potential Treatment of Severe Cases of COVID-19 2020-12-23 10:09
RedHill's Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Continue 2020-12-22 20:38
Overweight and Obese Subjects Dosed with ASC41 Tablets in a Phase Ib Trial 2020-12-22 19:18
111, Inc. Announces Additional Round of New Capital Injection 2020-12-22 17:22
Leapstack has completed tens of millions of yuan in B plus round fundraising, expending intelligent risk control territory 2020-12-22 15:50
Alterity and UniQuest partner to reverse bacterial resistance to antibiotics 2020-12-22 05:42
DW Healthcare Partners V, L.P. Announces Commencement of the Tender Offer for All Outstanding Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd 2020-12-21 23:07
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004 2020-12-21 23:00
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004 2020-12-21 23:00
Servier to Acquire Agios Pharmaceuticals' Oncology Business 2020-12-21 22:26
Major Breakthrough: DragonFly-T™ First Transcatheter Tricuspid Valve Repair Surgery in China 2020-12-21 22:18
LT1001 (Naldebain(R)), an Extended-Release Analgesic Injection, Received Its Second Approval from Singapore's HSA 2020-12-21 22:08
Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson's Progression Markers Initiative 2020-12-21 21:00
BioVaxys Vaccine Platform Stimulates Robust T-cell Response Against Viral Antigens 2020-12-21 21:00
Neusoft Medical has reached a strategic cooperation of Sino-Pakistan Healthcare in Pakistan 2020-12-21 19:18
ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate development of the treatment 2020-12-21 10:43
Peijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China 2020-12-21 10:00
Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy 2020-12-21 08:00
Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration 2020-12-18 23:30
Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation 2020-12-18 21:29